These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12413581)

  • 1. D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation.
    Mahé I; Drouet L; Chassany O; Mazoyer E; Simoneau G; Knellwolf AL; Caulin C; Bergmann JF
    Thromb Res; 2002 Jul; 107(1-2):1-6. PubMed ID: 12413581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence.
    Danese E; Montagnana M; Cervellin G; Lippi G
    Ann Med; 2014 Sep; 46(6):364-71. PubMed ID: 24863960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
    Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY
    Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N; Mavri A; Kosmelj K; Stegnar M
    Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
    Sadanaga T; Sadanaga M; Ogawa S
    J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
    Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
    Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
    Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
    Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
    Kamath S; Blann AD; Chin BS; Lip GY
    J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma D-dimer volume as a subclinical marker of thrombotic risk in elderly patients with atrial fibrillation.].
    Zadvorev SF; Zamytskaya AA; Piskunov DP; Pushkin AS; Yakovlev AA
    Adv Gerontol; 2019; 32(3):415-421. PubMed ID: 31512429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
    Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
    Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation.
    Wang TL; Hung CR; Chang H
    Cardiology; 2004; 102(2):115-8. PubMed ID: 15133314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
    Inoue H; Nozawa T; Okumura K; Jong-Dae L; Shimizu A; Yano K
    Chest; 2004 Sep; 126(3):687-92. PubMed ID: 15364743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter.
    Sakurai K; Hirai T; Nakagawa K; Kameyama T; Nozawa T; Asanoi H; Inoue H
    Chest; 2003 Nov; 124(5):1670-4. PubMed ID: 14605033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer can predict survival in patients with chronic atrial fibrillation.
    Mahé I; Drouet L; Simoneau G; Minh-Muzeaux S; Caulin C; Bergmann JF
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):413-7. PubMed ID: 15205590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic aortic plaque enhances hypercoagulability in patients with nonrheumatic atrial fibrillation.
    Nakagawa K; Hirai T; Sakurai K; Ohara K; Nozawa T; Inoue H
    Circ J; 2007 Jan; 71(1):52-6. PubMed ID: 17186978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
    Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
    Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
    Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW
    Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.